Download Sample
Add to CartProtein Chip Market
By Chip Type;
Analytical Protein Microarrays, Functional Protein Microarrays, Reverse-Phase Protein Microarrays, Glycan Microarrays, Peptide/Phospho-Specific Microarrays and Custom/Cell-Free Protein MicroarraysBy Surface Chemistry;
Nitrocellulose-Coated Slides, Hydrogel-Coated Slides, 3D Polymer Coatings and Other ChemistriesBy Application;
Antibody Characterisation & Epitope Mapping, Clinical Diagnostics, Drug Discovery & Development, Proteomics & Biomarker Discovery, Autoimmune & Infectious-Disease Profiling and Personalised/Precision MedicineBy End User;
Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and Contract Research OrganisationsBy Detection Technology;
Fluorescence-Based, Label-Free (SPR) and Chemiluminescence/ColorimetricBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Protein Chip Market Overview
Protein Chip Market (USD Million)
Protein Chip Market was valued at USD 902.09 million in the year 2024. The size of this market is expected to increase to USD 1,511.30 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.7%.
Protein Chip Market
*Market size in USD million
CAGR 7.7 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 7.7 % |
| Market Size (2024) | USD 902.09 Million |
| Market Size (2031) | USD 1,511.30 Million |
| Market Concentration | Medium |
| Report Pages | 364 |
Major Players
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA (EMD Millipore)
- Illumina, Inc.
- GE Healthcare
- Horiba, Ltd.
- Randox Laboratories Ltd.
- Sigma-Aldrich Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Protein Chip Market
Fragmented - Highly competitive market without dominant players
Protein Chip Market is witnessing strong momentum due to the rising demand for high-throughput proteomic technologies across biomedical research and diagnostics. Protein chips offer the ability to detect and analyze multiple proteins simultaneously, significantly enhancing efficiency in disease research and biomarker identification. Around 55% of research institutions have integrated protein chip platforms to streamline large-scale protein studies.
Expansion in Clinical Diagnostic Applications
A major driver for this market is its expanding role in clinical diagnostics, particularly for cancer, autoimmune, and infectious diseases. Protein chips support early and accurate detection through protein expression profiling, aligning well with precision medicine goals. Currently, diagnostic use accounts for over 40% of all protein chip applications, highlighting their rising clinical significance.
Technological Innovations Enhancing Sensitivity
Ongoing advances in protein microarray fabrication and detection technologies continue to fuel market growth. Improvements in surface chemistry and nanotechnology are boosting both sensitivity and reliability, enabling the detection of low-concentration biomarkers. Roughly 30% of proteomic technology innovations are focused on advancing protein chip capabilities, reinforcing their value in analytical research.
Pharmaceutical Industry Applications
Pharmaceutical companies are increasingly utilizing protein chips for drug discovery, toxicity testing, and protein-target interaction studies. These tools help shorten drug development timelines and improve therapeutic targeting. About 35% of protein chip implementations now serve pharmaceutical R&D, demonstrating their strategic importance in the development of new drugs.
Protein Chip Market Key Takeaways
-
Proteomics & biomarker research tailwinds are fueling adoption of protein chips as high-throughput platforms for understanding protein interactions, disease mechanisms and drug targets.
-
Diagnostics & personalised medicine momentum is increasing as protein chips enable multiplexed assays, deeper insight into post-translational modification and molecular profiling needed in precision healthcare.
-
Technology innovation matters advances in microarray platforms, surface chemistry, data analysis and integration with AI/ML improve sensitivity, throughput and cost-effectiveness of protein chip systems.
-
Research institutions drive volume as academic, pharmaceutical & biotechnology labs remain leading end-users, while clinical applications and diagnostics uptake gradually increase.
-
Regional growth divergence North America holds the largest market share due to established infrastructure and R&D expenditure; Asia-Pacific is emerging fastest, driven by growing biotech investment and increasing healthcare access.
-
Cost & standardisation challenges persist high upfront system cost, protein availability and reproducibility issues limit certain applications; overcoming these will broaden market access.
-
Service & value-add opportunities expand as service models like contract proteomics, custom arrays and data-analytics-as-a-Service become important for vendors looking to monetise beyond hardware sales.
Protein Chip Market Recent Developments
-
In July 2023, Bio-Rad introduced an advanced range of protein chips featuring high-density binding sites, specifically designed to enhance the precision of protein interaction analysis in cancer research and broader disease studies.
-
In 2023, Agilent Technologies broadened its protein chip offerings by integrating an AI-powered analysis platform, significantly boosting the precision and efficiency of biomarker detection in clinical diagnostic applications.
Protein Chip Market Segment Analysis
In this report, Protein Chip Market has been segmented by Chip Type, Surface Chemistry, Application, End User, Detection Technology, and Geography. The market is driven by the growing demand for high-throughput analysis, personalized medicine, and advancements in proteomics and biomarker discovery.
Protein Chip Market, Segmentation by Chip Type
The Chip Type segmentation includes Analytical Protein Microarrays, Functional Protein Microarrays, Reverse-Phase Protein Microarrays, Glycan Microarrays, Peptide/Phospho-Specific Microarrays, and Custom/Cell-Free Protein Microarrays. Each chip type offers specific advantages in protein analysis, enabling high-throughput screening, biomarker discovery, and diagnostic applications.
Analytical Protein Microarrays
Analytical protein microarrays are used to study the interactions between proteins and other molecules. These chips are commonly used in high-throughput applications to analyze protein expression and interactions in large-scale screenings.
Functional Protein Microarrays
Functional protein microarrays are designed to study protein function, including enzyme activity, protein-protein interactions, and receptor-ligand binding. They are widely used in drug discovery and disease biomarker identification.
Reverse-Phase Protein Microarrays
Reverse-phase protein microarrays are used for detecting and quantifying protein expression levels. These arrays are commonly used in clinical diagnostics and biomarker discovery applications.
Glycan Microarrays
Glycan microarrays are used to study glycan-protein interactions. They are essential in glycomics research, especially for understanding the role of glycans in disease mechanisms such as cancer and infectious diseases.
Peptide/Phospho-Specific Microarrays
Peptide and phospho-specific microarrays are used to detect and analyze post-translational modifications of proteins, such as phosphorylation. These are crucial in signaling pathway studies and therapeutic target identification.
Custom/Cell-Free Protein Microarrays
Custom and cell-free protein microarrays offer flexibility in experimental design and are often used in personalized medicine applications. They allow researchers to generate specific protein arrays tailored to their research needs.
Protein Chip Market, Segmentation by Surface Chemistry
The Surface Chemistry segmentation includes Nitrocellulose-Coated Slides, Hydrogel-Coated Slides, 3D Polymer Coatings, and Other Chemistries. Surface chemistry plays a critical role in ensuring the stability, specificity, and sensitivity of protein chips.
Nitrocellulose-Coated Slides
Nitrocellulose-coated slides are widely used due to their ability to immobilize proteins effectively for subsequent analysis. These are commonly used in protein microarrays for diagnostics and high-throughput screening.
Hydrogel-Coated Slides
Hydrogel-coated slides offer a high degree of flexibility and functionality, providing a suitable environment for protein-protein interactions. These slides are gaining popularity in research focused on protein binding and interaction studies.
3D Polymer Coatings
3D polymer coatings enhance the surface area and stability of protein chips. These coatings are ideal for applications requiring high-density protein immobilization and are widely used in proteomics research.
Other Chemistries
Other surface chemistries, including silane-based coatings and proprietary polymer coatings, are used to enhance protein immobilization efficiency and improve assay performance in various applications.
Protein Chip Market, Segmentation by Application
The Application segmentation includes Antibody Characterisation & Epitope Mapping, Clinical Diagnostics, Drug Discovery & Development, Proteomics & Biomarker Discovery, Autoimmune & Infectious-Disease Profiling, and Personalised/Precision Medicine. These applications reflect the diverse uses of protein chips in advancing research, diagnostics, and treatment development.
Antibody Characterisation & Epitope Mapping
Protein chips are used in antibody characterization and epitope mapping to identify and analyze the binding sites of antibodies. This is crucial for vaccine development, therapeutic antibody development, and autoimmune disease research.
Clinical Diagnostics
Protein chips play a significant role in clinical diagnostics by enabling the detection of biomarkers for various diseases, including cancer, infectious diseases, and genetic disorders. Their high-throughput capabilities make them ideal for screening large patient populations.
Drug Discovery & Development
In drug discovery and development, protein chips are used to identify potential drug targets, screen for therapeutic compounds, and evaluate the efficacy of drugs in preclinical stages. These applications are essential in accelerating the drug development process.
Proteomics & Biomarker Discovery
Proteomics and biomarker discovery are key areas where protein chips are used for high-throughput protein analysis. They help identify novel biomarkers for disease diagnosis, prognosis, and treatment monitoring.
Autoimmune & Infectious-Disease Profiling
Protein chips are used to profile autoimmune and infectious diseases by identifying specific protein markers that indicate disease presence or progression. This is crucial for developing targeted therapies and personalized treatment plans.
Personalised/Precision Medicine
Protein chips play a vital role in personalized and precision medicine by enabling the identification of patient-specific biomarkers. This allows for the development of tailored therapies that offer improved efficacy and reduced side effects.
Protein Chip Market, Segmentation by End User
The End-User segmentation includes Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Contract Research Organisations. These end-users leverage protein chip technologies for various applications such as diagnostics, drug development, and research.
Hospitals & Clinics
Hospitals and clinics are key end-users of protein chip technologies, particularly in the field of diagnostics. They use protein chips for disease detection, biomarker profiling, and patient monitoring to support clinical decision-making.
Diagnostic Laboratories
Diagnostic laboratories use protein chips for high-throughput screening of biomarkers and disease profiling. These labs play a central role in applying protein chips in routine diagnostic procedures and clinical trials.
Academic & Research Institutes
Academic and research institutes are major players in advancing the field of protein chip technology. These institutions use protein chips in various research areas, including proteomics, biomarker discovery, and drug development.
Pharmaceutical & Biotechnology Companies
Pharmaceutical and biotechnology companies use protein chips to identify drug targets, screen potential drug candidates, and develop personalized medicine. Protein chips are also used for biomarker discovery in clinical trials.
Contract Research Organisations
Contract research organizations (CROs) play a vital role in applying protein chips for drug testing, clinical trials, and research studies. They offer outsourced services to pharmaceutical and biotechnology companies, leveraging protein chip technologies to enhance research outcomes.
Protein Chip Market, Segmentation by Detection Technology
The Detection Technology segmentation includes Fluorescence-Based, Label-Free (SPR), and Chemiluminescence/Colorimetric technologies. Each detection method provides distinct advantages in terms of sensitivity, detection speed, and application suitability.
Fluorescence-Based
Fluorescence-based detection is one of the most commonly used methods for protein chips. This technology uses fluorescent markers to detect protein interactions, offering high sensitivity and resolution, making it ideal for biomarker discovery and disease diagnostics.
Label-Free (SPR)
Label-free detection, such as Surface Plasmon Resonance (SPR), does not require fluorescent or radioactive labeling, making it a non-invasive and cost-effective method. SPR is widely used for studying protein-protein interactions and binding kinetics.
Chemiluminescence/Colorimetric
Chemiluminescence and colorimetric detection technologies use chemical reactions to produce light or color change, enabling the detection of proteins with high sensitivity. These technologies are often used in clinical diagnostics and research applications.
Protein Chip Market, Segmentation by Geography
In this report, Protein Chip Market has been segmented by Geography into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
North America
North America dominates the market due to the presence of advanced healthcare infrastructure, widespread adoption of cutting-edge protein chip technologies, and increasing demand for personalized medicine and drug discovery solutions.
Europe
Europe shows steady growth, supported by government initiatives, increasing investment in healthcare R&D, and the growing demand for high-throughput analysis in pharmaceutical and biotechnology sectors.
Asia Pacific
Asia Pacific is expected to experience rapid growth, driven by improving healthcare infrastructure, increasing research activities, and the rising demand for protein chips in emerging markets like China and India.
Middle East & Africa
The Middle East & Africa region is gradually adopting protein chip technologies due to increasing investments in healthcare, rising awareness of proteomics research, and expanding healthcare access in key countries.
Latin America
Latin America is witnessing steady market growth, with increasing healthcare investments, research initiatives, and expanding access to advanced protein analysis tools in countries like Brazil and Mexico.
Protein Chip Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Protein Chip Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Advancements in Proteomics
- Rising Demand for Personalized Medicine
-
Expanding Applications in Biomedical Research - The increasing scope of biomedical research is playing a crucial role in driving the growth of the protein chip market. As the demand for high-throughput, cost-effective, and accurate protein analysis tools rises, protein chips are becoming central to a wide range of research applications. These microarrays allow researchers to study thousands of proteins simultaneously, enabling deeper insights into disease pathways, biomarker discovery, and drug development. Their ability to streamline complex protein profiling processes makes them indispensable in both academic institutions and pharmaceutical R&D labs.
Protein chips are increasingly being used to investigate complex medical conditions such as cancer, autoimmune diseases, and neurodegenerative disorders. They provide a powerful platform for analyzing protein expression levels, mutations, and post-translational modifications, all of which are critical for identifying novel therapeutic targets. The ability to analyze multiple proteins in a single experiment not only improves efficiency but also enhances the accuracy and depth of scientific insights, supporting the rapid advancement of translational medicine.
The growing emphasis on personalized medicine has further accelerated the adoption of protein chips. These technologies support the analysis of individual protein profiles that can inform personalized treatment plans and improve diagnostic precision. As healthcare moves toward more customized and data-driven approaches, there is a rising need for tools that can deliver real-time, sensitive, and multiplexed data. Protein chips fulfill this requirement and are becoming a preferred solution for precision research and diagnostics.
Global expansion in the biotechnology and life sciences sector, along with increased government funding and research collaborations, is further boosting the adoption of protein chip technology. Public and private investments are promoting the development of next-generation proteomics tools and their integration into mainstream research pipelines. As the applications of biomedical research continue to grow, protein chips are expected to play an even more significant role, positioning the market for consistent and long-term growth.
Restraints
- Emerging applications in cancer diagnostics
- Expansion of research in autoimmune diseases
-
Technological innovation in microarray platforms - Although technological innovation in microarray platforms has propelled advancements in proteomics, it also introduces challenges that can restrain the growth of the protein chip market. The emergence of more advanced technologies like next-generation sequencing (NGS),mass spectrometry, and lab-on-a-chip systems is drawing attention away from traditional protein chips. These newer tools often providehigher resolution,greater flexibility, and broader applications, making them increasingly preferred by researchers and institutions focused on multi-omics studies and large-scale biomarker discovery.
As these alternative platforms gain momentum, the demand for conventional protein chip technologies may decline. Many researchers are transitioning to methods that offer improved sensitivity, expanded multiplexing capabilities, and integration with other genomic or transcriptomic analyses. In comparison, some protein chips may not match the evolving expectations for data depth or adaptability, especially in high-end research applications. This technological shift may limit their appeal in more competitive or innovation-driven environments.
For manufacturers, the constant need to innovate poses operational and financial pressures. Companies must invest heavily in R&D to update their platforms and maintain relevance in the face of fast-moving alternatives. This includes upgrading hardware, software, and assay design, as well as ensuring compatibility with new research protocols. Smaller firms or those with limited resources may find it challenging to keep pace, resulting in reduced competitiveness and a potential loss of market share.
On the user side, frequent changes in platform technologies create barriers related to training, infrastructure upgrades, and data analysis adaptation. Switching to newer systems often involves a learning curve and investment in new equipment or software, which can delay adoption and create resistance among labs with established workflows. Unless protein chip technologies evolve to offer greater integration, automation, and analytical depth, they may struggle to maintain traction in a market that increasingly values flexibility and precision.
Opportunities
- Technological Innovations
- Expansion in Clinical Diagnostics
-
Emerging Markets and Untapped Potential - Emerging markets present substantial growth opportunities for the protein chip market, offering access to regions where the use of advanced biotechnology tools is still developing. Countries across Asia-Pacific, Latin America, the Middle East, and Africa are rapidly advancing in terms of healthcare infrastructure, R&D investments, and awareness of modern diagnostic technologies. These improvements are creating a favorable environment for the adoption of protein chip technologies in both clinical and research domains.
With healthcare systems evolving and a growing focus on early disease detection and personalized medicine, there is increasing demand for affordable, high-throughput diagnostic solutions. Protein chips enable multiplexed protein analysis with high sensitivity and minimal sample volumes, making them ideal for regions aiming to modernize diagnostics while managing costs. Their efficiency and versatility allow faster screening of biomarkers and support better decision-making in public health and clinical research.
Government initiatives and international research partnerships are also accelerating the integration of proteomics in emerging economies. National healthcare strategies targeting diseases like cancer, diabetes, and cardiovascular disorders are driving the demand for tools that can enhance prevention, diagnosis, and treatment outcomes. Additionally, the rise of local academic institutions and biotech startups is contributing to a growing need for scalable, user-friendly platforms such as protein chips that can support both discovery and applied research.
With fewer established competitors and large untapped user bases, emerging markets provide an ideal landscape for protein chip manufacturers to expand their presence. Companies that invest in local production capabilities, training programs, and technical support services can gain a competitive edge and build long-term customer loyalty. As access to advanced diagnostics continues to grow, these markets are expected to significantly contribute to the sustained expansion of the protein chip industry worldwide.
Protein Chip Market Competitive Landscape Analysis
Protein Chip Market is witnessing strong growth driven by increasing demand in proteomics research, diagnostics, and drug discovery. Leading players are implementing strategic partnerships and mergers to strengthen market positioning, with top companies controlling nearly 40% of revenue. Continuous innovation in chip technology and assay sensitivity shapes the future outlook.
Market Structure and Concentration
The market exhibits moderate concentration, with top-tier firms holding around 60% of total market share. Strategic collaboration and mergers enhance competitiveness. Mid-tier companies focus on multiplexing capabilities and novel substrates, while smaller players leverage niche applications and regional research networks to drive incremental growth and reinforce market positioning.
Brand and Channel Strategies
Brands adopt multi-channel strategies, combining direct sales, distributor networks, and partnerships with research institutions, contributing nearly 45% of sales. Collaborative partnerships enhance visibility and adoption. Marketing emphasizes reliability, high-throughput capabilities, and reproducibility, fostering market expansion across academic, pharmaceutical, and biotechnology segments.
Innovation Drivers and Technological Advancements
Advances in nanotechnology, surface chemistry, and detection methods are driving significant innovation, improving sensitivity and specificity of protein chips. Investments in R&D and technological advancements enable development of high-density arrays. Collaborative initiatives accelerate product enhancement and support overall market growth in research and clinical applications.
Regional Momentum and Expansion
North America and Europe lead regional expansion, contributing nearly 55% of market revenue due to established research infrastructure and strong adoption. Asia-Pacific is emerging rapidly with increasing investment in life sciences and biotechnology. Regional strategies include local collaborations and tailored solutions, driving sustained growth and strengthening competitive positioning.
Future Outlook
Protein Chip Market is expected to maintain strong growth through continuous innovation, strategic mergers, and collaborative partnerships. Focus on technological advancements and regional expansion will drive adoption across research, diagnostics, and drug discovery. Top-tier companies are projected to retain around 65% of market share, shaping a competitive and promising future outlook.
Key players in Protein Chip Market include:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Illumina, Inc.
- GE Healthcare
- Horiba, Ltd.
- Randox Laboratories Ltd.
- Sigma-Aldrich Corporation
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Chip Type
- Market Snapshot, By Surface Chemistry
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Detection Technology
- Market Snapshot, By Region
- Protein Chip Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Advancements in Proteomics
- Rising Demand for Personalized Medicine
- Expanding Applications in Biomedical Research
- Restraints
- Emerging applications in cancer diagnostics
- Expansion of research in autoimmune diseases
- Technological innovation in microarray platforms
- Opportunities
- Technological Innovations
- Expansion in Clinical Diagnostics
- Emerging Markets and Untapped Potential
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Protein Chip Market, By Chip Type, 2021 - 2031 (USD Million)
- Analytical Protein Microarrays
- Functional Protein Microarrays
- Reverse-Phase Protein Microarrays
- Glycan Microarrays
- Peptide / Phospho-specific Microarrays
- Custom / Cell-free Protein Microarrays
- Protein Chip Market, By Surface Chemistry, 2021 - 2031 (USD Million)
- Nitrocellulose-coated Slides
- Hydrogel-coated Slides
- 3-D Polymer Coatings
- Other Chemistries
- Protein Chip Market, By Application, 2021 - 2031 (USD Million)
- Antibody Characterisation & Epitope Mapping
- Clinical Diagnostics
- Drug Discovery & Development
- Proteomics & Biomarker Discovery
- Auto-immune & Infectious-disease Profiling
- Personalised / Precision Medicine
- Protein Chip Market, By End User, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organisations
- Protein Chip Market, By Detection Technology, 2021 - 2031 (USD Million)
- Fluorescence-based
- Label-free (SPR)
- Chemiluminescence / Colorimetric
- Protein Chip Market, By Geography, 2021 - 2031 (USD Million)
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- North America
- United States
- Canada
- Latin America
- Protein Chip Market, By Chip Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Illumina, Inc.
- GE Healthcare
- Horiba, Ltd.
- Randox Laboratories Ltd.
- Sigma-Aldrich Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market